HEMOSTATICS PHARMACEUTICALS S.L.

A Healthtech startup included in the Barcelona & Catalonia Startup Hub

HEMOSTATICS. Barcelona & Catalonia Startup Hub

HEMOSTATICS

HEMOSTATICS PHARMACEUTICALS S.L.
Carrer Baldiri Reixac (pq. Científico Barcelona), 4 12 08028 Barcelona
https://hemostatics.com/

A cima spinoff company dedicated to research on the reduction of disabling and life-threatening bleeding conditions. its proprietary technology aims to address unmet medical needs by using an innovative mechanism of action to inhibit fibrinolysis.

Industries & Technologies

Industries: Healthtech
Technologies: Biotechnology
Other fields: Deeptech

Financial data

Funding stage:
Founded: 2020
Employees:

Other information

Business model: Development & Manufacturing, R+D+I Services
Target: -
Spinoff participants: University (Cima Universidad de Navarra)

Other startups near startup HEMOSTATICS

similar companies

IPROTEOS
Iproteos seeks to improve human health by creating therapeutics for diseases that are currently difficult to target.  Our IPROTech platform quickly and efficiently delivers cell-permeable and...
  • Healthtech
  • Biotechnology
PHARMACELERA
Pharmacelera offers integrated hardware-software solutions, pharmaceutical design based on ligands based on 20 years of research at the University of Barcelona.
  • Healthtech
  • Biotechnology
  • Deeptech
EMBRYOTOOLS
Embryotools supplies control testing products for the ivf industry. it also supplies independent scientific and clinical consulting services for reproductive centers in order to improve results based ...
  • Healthtech
  • Biotechnology

The Barcelona & Catalonia Startup Hub.

It is a Catalan Government project offering updated information on the Catalan startup ecosystem; gathering and consolidating data from internal databases as well as other local and international sources.

Collaborators of Barcelona & Catalonia Startup Hub.

We teamed up with business associations, universities and startup incubators to create the Barcelona & Catalonia Startup Hub.